🇺🇸 FDA
Pipeline program

First-in-Human Trial of DS3610a in Participants with Advanced Solid Tumors

DS3610-071

Phase 1 other active

Quick answer

First-in-Human Trial of DS3610a in Participants with Advanced Solid Tumors for Advanced Solid Tumors is a Phase 1 program (other) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Daiichi Sankyo Europe GmbH
Indication
Advanced Solid Tumors
Phase
Phase 1
Modality
other
Status
active

Clinical trials